Skip to main content
Paige AI logo

Paige AI

Updated Mar 24, 2026

Everything you need to know about Paige AI — from their $241M in funding to who's backing them.

🇺🇸United StatesAcquiredAI Healthcare

Out of 100

🇺🇸

HQ

United States

🗓

Founded

2018

💰

Raised

$241M

🏷️

Stage

Acquired

👥

Team

100-500

Paige AI develops AI-powered pathology software that assists pathologists in identifying cancer and other diseases in digital whole-slide images. The platform received the first-ever FDA authorization for an AI-based primary diagnostic tool in pathology, a milestone that establishes regulatory precedent for clinical AI deployment in histopathology workflows.\n\nThe company raised approximately

Is this your company? Claim it →

Key Facts

  • Paige AI has raised a total of $241M in disclosed funding across 1 funding rounds.
  • Paige AI was founded in 2018 by Leo Grady and is headquartered in United States.
  • Paige AI employs approximately 100-500 people.
  • Paige AI operates in the AI Healthcare category and is currently at the Acquired stage.
  • Paige AI has an Awaira Score of 65/100, ranking it among the tracked AI companies on Awaira.
  • Paige AI's most recent funding round was a Series C of $100M closed in November 2021, led by Goldman Sachs.

Source: Awaira · Updated Mar 24, 2026

N/A

Post-money

$241M

All rounds

65/100

2018

100-500 employees

Strengths

Strong Awaira Score of 65/100

Large team of 100-500+ employees

Based in the US, the world's largest AI market

Considerations

!

Valuation not publicly disclosed

Analysis based on publicly available data. Not investment advice.

⚠️ ESTIMATE
💵Est. Annual Revenue
$20M–$100M estimated ARR

Awaira estimate based on public data. Not financial advice.

How does Paige AI stack up against competitors?

MetricPaige AIButterfly NetworkTempusAlan
Awaira Score65/10085/10084/10083/100
Total Raised$241M$370M$1.05B$750M
ValuationN/A$957M$8.1B$5.83B
StageAcquiredPublicPublicSeries D
Founded2018201120152016
Employees100-500500-10002500500-1000
Country🇺🇸🇺🇸🇺🇸🇫🇷
L

Leo Grady

Founder & CEO

View founder profile →
StageAcquired
Employees100-500
Country🇺🇸 United States
Connect
Goldman SachsBONDCasdin Capital
Inactive
1 round
Series CLatest

Led by Goldman Sachs

$100M

Nov 2021

Frequently Asked Questions

What is Paige AI's valuation?
No public valuation has been disclosed yet. The company operates in the AI Healthcare space and may reveal this in a future round.
Who invested in Paige AI?
Known backers include Goldman Sachs, BOND, Casdin Capital. These investors have supported the company through various funding rounds.
When did Paige AI last raise funding?
Capital was most recently raised through a Series C of $100M in November 2021. The round was led by Goldman Sachs.
How many employees does Paige AI have?
The team is roughly 100-500 people, headquartered in United States.
What does Paige AI do?
Paige AI develops AI-powered pathology software that assists pathologists in identifying cancer and other diseases in digital whole-slide images. The platform received the first-ever FDA authorization for an AI-based primary diagnostic tool in pathology, a milestone that establishes regulatory precedent for clinical AI deployment in histopathology workflows. Founded in 2018, Paige AI is categorized under AI Healthcare.
Who founded Paige AI?
Behind the company is Leo Grady, who got it off the ground in 2018 in United States. Leo Grady serves as Founder & CEO.
Is Paige AI profitable?
Profitability details aren't publicly disclosed. The company has raised $241M in total funding and is currently at the Acquired stage.
Where is Paige AI headquartered?
Headquarters are in United States 🇺🇸. The company operates in the AI Healthcare sector and was established in 2018.
⚔️

Compare Paige AI

See how Paige AI stacks up against competitors in valuation, funding, team size, and Awaira Score.

Browse all comparisons →